BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 24261779)

  • 1. Refractory pseudoseptic arthritis in Behçet's disease successfully treated with infliximab: a case report and literature review.
    Sifuentes Giraldo WA; Guillén Astete CA; Murillo Romero C; Amil Casas I; Rodríguez García AM; Bachiller Corral FJ
    Mod Rheumatol; 2014 Jan; 24(1):199-205. PubMed ID: 24261779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Spondylarthropathy with Behçet's disease: response to infliximab].
    Toussirot E; Schwartz C; Hafsaoui C; Bossert M; Bertolini E; Wendling D
    Presse Med; 2009; 38(7-8):1183-5. PubMed ID: 19395229
    [No Abstract]   [Full Text] [Related]  

  • 3. Remission of Behçet's syndrome with TNFalpha blocking treatment.
    Rozenbaum M; Rosner I; Portnoy E
    Ann Rheum Dis; 2002 Mar; 61(3):283-4. PubMed ID: 11830448
    [No Abstract]   [Full Text] [Related]  

  • 4. Infliximab in refractory uveitis due to Behçet's disease.
    Wechsler B; Sablé-Fourtassou R; Bodaghi B; Huong DL; Cassoux N; Badelon I; Fain O; LeHoang P; Piette JC
    Clin Exp Rheumatol; 2004; 22(4 Suppl 34):S14-6. PubMed ID: 15515776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of leg ulcers in Behçet's disease using adalimumab plus methotrexate after the failure of infliximab.
    Atzeni F; Leccese P; D'Angelo S; Sarzi-Puttini P; Olivieri I
    Clin Exp Rheumatol; 2010; 28(4 Suppl 60):S94. PubMed ID: 20868581
    [No Abstract]   [Full Text] [Related]  

  • 6. Switching to adalimumab is effective in a case of neuro-Behcet's disease refractory to infliximab.
    Leccese P; D'Angelo S; Angela P; Coniglio G; Olivieri I
    Clin Exp Rheumatol; 2010; 28(4 Suppl 60):S102. PubMed ID: 20868587
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful treatment of life-threatening intestinal ulcer in Behçet's disease with infliximab: rapid healing of Behçet's ulcer with infliximab.
    Ju JH; Kwok SK; Seo SH; Yoon CH; Kim HY; Park SH
    Clin Rheumatol; 2007 Aug; 26(8):1383-5. PubMed ID: 17039261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of a single dose of infliximab in the treatment of Behçet's disease uveitis.
    Arayssi T; Hamra R; Homeidan F; Uthman I; Awwad ST; Mroue K; Mansour W; Bashshur ZF
    Clin Exp Rheumatol; 2005; 23(3):427. PubMed ID: 15971438
    [No Abstract]   [Full Text] [Related]  

  • 9. Infliximab for the treatment of Neuro-Behçet's disease: a case series and review of the literature.
    Pipitone N; Olivieri I; Padula A; D'angelo S; Nigro A; Zuccoli G; Boiardi L; Salvarani C
    Arthritis Rheum; 2008 Feb; 59(2):285-90. PubMed ID: 18240181
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of infliximab on threatening panuveitis in Behçet's disease.
    Muñoz-Fernández S; Hidalgo V; Fernández-Melón J; Schlincker A; Martín-Mola E
    Lancet; 2001 Nov; 358(9293):1644. PubMed ID: 11716917
    [No Abstract]   [Full Text] [Related]  

  • 11. Erosive arthritis in a patient with Behçet's disease.
    Düzgün N; Ateş A
    Rheumatol Int; 2003 Sep; 23(5):265-7. PubMed ID: 12879263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of infliximab on sight-threatening panuveitis in Behçet's disease.
    Sfikakis PP; Theodossiadis PG; Katsiari CG; Kaklamanis P; Markomichelakis NN
    Lancet; 2001 Jul; 358(9278):295-6. PubMed ID: 11498218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intra-articular anti-tumor necrosis factor alpha antibody in recalcitrant arthritis of Behçet's disease.
    Andonopoulos AP; Meimaris N; Daoussis D; Bounas A; Yiannopoulos G
    Clin Exp Rheumatol; 2003; 21(4 Suppl 30):S57-8. PubMed ID: 14727465
    [No Abstract]   [Full Text] [Related]  

  • 14. Infliximab in the treatment of posterior uveitis in Behçet's disease. Long term follow up in four patients.
    Lanthier N; Parc C; Scavennec R; Dhôte R; Brézin AP; Guillevin L
    Presse Med; 2005 Jul; 34(13):916-8. PubMed ID: 16142147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behçet's disease with refractory uveoretinitis.
    Ohno S; Nakamura S; Hori S; Shimakawa M; Kawashima H; Mochizuki M; Sugita S; Ueno S; Yoshizaki K; Inaba G
    J Rheumatol; 2004 Jul; 31(7):1362-8. PubMed ID: 15229958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infliximab in the treatment of hepatic vein thrombosis (Budd-Chiari syndrome) in three patients with Behcet's syndrome.
    Seyahi E; Hamuryudan V; Hatemi G; Melikoglu M; Celik S; Fresko I; Yurdakul S; Yazici H
    Rheumatology (Oxford); 2007 Jul; 46(7):1213-4. PubMed ID: 17478465
    [No Abstract]   [Full Text] [Related]  

  • 17. Behçet's disease: successful treatment with infliximab in 7 patients with severe vascular manifestations. A retrospective analysis.
    Adler S; Baumgartner I; Villiger PM
    Arthritis Care Res (Hoboken); 2012 Apr; 64(4):607-11. PubMed ID: 22162223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of severe Behçet's disease with anti-TNF-alpha: infliximab. A case report].
    Andreu M; Ramanoelina J; Fajnkuchen F; Mouthon L; Cohen P; Laroche L; Guillevin L
    Ann Med Interne (Paris); 2002 Oct; 153(6):414-5. PubMed ID: 12486393
    [No Abstract]   [Full Text] [Related]  

  • 19. Infliximab for the treatment of resistant oral ulcers in Behçet's disease: a case report and review of the literature.
    Almoznino G; Ben-Chetrit E
    Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S99-102. PubMed ID: 17949561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of infliximab on refractory uveitis in Behcet's disease.
    Sayarlioglu M; Cinal A; Topcu N; Demirok A
    Ann Pharmacother; 2004 May; 38(5):901-2. PubMed ID: 15010522
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.